Related Experiment Video
Updated: Feb 13, 2026

Acute Myocardial Infarction in Rats
Published on: February 16, 2011
Myocardial reperfusion for acute myocardial infarction under an optimized antithrombotic medication: What can you
Samuel Pinelli1, Nelly Agrinier2, Nidhal Bouchahda1
1CHU Nancy, Département de Cardiologie, Nancy F-54000, France.
Insights
Different antithrombotic strategies did not impact reperfusion in STEMI patients undergoing primary PCI. Optimal tissue reperfusion remains a challenge, achieved in only half of cases despite earlier interventions.
Area of Science:
- Cardiology
- Interventional Cardiology
- Pharmacology
Background:
- ST-elevation myocardial infarction (STEMI) requires rapid reperfusion therapy.
- Primary percutaneous coronary intervention (pPCI) is the standard treatment for STEMI.
- Optimizing both macrovascular and microvascular reperfusion is crucial for myocardial salvage.
Purpose of the Study:
- To evaluate the impact of different intravenous antithrombotic strategies on epicardial, microvascular, and tissue reperfusion in STEMI patients prior to pPCI.
- To identify if pre-admission antithrombotic choices influence reperfusion outcomes.
Main Methods:
- A cohort of 488 STEMI patients undergoing pPCI were analyzed.
- Patients received prehospital bivalirudin or heparin, with or without glycoprotein IIb/IIIa inhibitors (GPI).
- Epicardial perfusion (TIMI flow), microvascular perfusion (corrected TIMI frame count [cTFC]), and ST resolution (STR) on ECG were assessed.
Main Results:
- Overall, 85.2% achieved TIMI 3 flow, 37.2% had cTFC ≤23, and 42.5% showed STR >70%.
- No significant differences in STR or cTFC were observed between the antithrombotic treatment groups.
- Multivariate analysis did not identify any specific antithrombotic treatment as predictive of optimal reperfusion outcomes.
Conclusions:
- While pPCI has improved, optimal tissue reperfusion is achieved in only about half of STEMI patients.
- Pre-hospital antithrombotic strategies did not significantly alter macrovascular or microvascular reperfusion success rates.
- Factors like pre-procedural TIMI 3 flow and symptom-to-balloon time are more predictive of ST resolution than the chosen antithrombotic agent.
Aims:
To assess both epicardiac macrovascular as well as microvascular and tissue reperfusion following different intravenous preadmission antithrombotic strategies prior primary PCI in STEMI patients.
Methods And Results:
Consecutive STEMI patients (n = 488) undergoing pPCI received prehospitally either bivalirudin (n = 179), bivalirudin and periprocedural GPIIb/IIIa inhibitors (GPI) (n = 109), heparin (n = 99) or heparin and periprocedural GPI (n = 101). Epicardial perfusion and microvascular perfusion were assessed by angiography (TIMI flow rate and corrected TIMI frame count [cTFC]) and by ECG (ST resolution [STR]). TIMI 3 flow was restored at the end of the procedure in 85.2% of the cases; cTFC of ≤23 was obtained in 37.2% of cases and STR >70% in 42.5% of the cases. The rates of STR >70% and cTFC ≤23 were not different between the three groups. Multivariate analysis did not identify a predictive antithrombotic treatment to obtain either post-procedural TIMI 3 flow rate or a STR rate >70%. TIMI 3 flow before procedure and delay first symptoms-balloon <6 h represented a positive predictive value of STR rate >70% and the LAD as infarct related artery a negative predictive value of STR rate of >70%.
Conclusion:
The process of myocardial reperfusion by pPCI continues to be improved with earlier reperfusion but an optimal tissular reperfusion was present in only half of the cases.
Related Concept Videos
Expected Value
Classical Conditioning in Daily Life
John B. Watson and Rosalie Rayner famously demonstrated the development of fear through classical conditioning in their experiment with Little Albert. They paired the...
Determination of Expected Frequency
Inhaled Medications
Optimal Foraging
Expected Frequencies in Goodness-of-Fit Tests

